Related Experiment Video
Updated: Nov 26, 2025

DNA Virus Detection System Based on RPA-CRISPR/Cas12a-SPM and Deep Learning
Published on: May 10, 2024
Nucleic Acid-Based Technologies Targeting Coronaviruses
Thi Khanh Le1, Clément Paris2, Khadija Shahed Khan3
1Centre de Recherche en Cancérologie de Marseille, CRCM, Inserm UMR1068, CNRS UMR7258, Aix-Marseille University U105, Institut Paoli-Calmettes Marseille, France; Department of Life Sciences, University of Science and Technology of Hanoi (USTH), Hanoi, Vietnam.
Abstract:
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently creating a global health emergency. This crisis is driving a worldwide effort to develop effective vaccines, prophylactics, and therapeutics. Nucleic acid (NA)-based treatments hold great potential to combat outbreaks of coronaviruses (CoVs) due to their rapid development, high target specificity, and the capacity to increase druggability. Here, we review key anti-CoV NA-based technologies, including antisense oligonucleotides (ASOs), siRNAs, RNA-targeting clustered regularly interspaced short palindromic repeats-CRISPR-associated protein (CRISPR-Cas), and mRNA vaccines, and discuss improved delivery methods and combination therapies with other antiviral drugs.
Insights
Nucleic acid treatments like antisense oligonucleotides, siRNAs, CRISPR-Cas, and mRNA vaccines show promise for combating coronavirus disease 2019 (COVID-19). This review explores these technologies, delivery methods, and combination therapies for effective antiviral strategies.
Area of Science:
- Virology
- Molecular Biology
- Drug Discovery
Background:
- The COVID-19 pandemic, caused by SARS-CoV-2, necessitates rapid development of medical countermeasures.
- Nucleic acid (NA)-based therapies offer advantages in speed, specificity, and druggability for combating coronavirus outbreaks.
Purpose of the Study:
- To review key nucleic acid-based technologies for anti-coronavirus applications.
- To discuss advancements in delivery methods and combination therapies for enhanced efficacy.
Main Methods:
- Review of existing literature on NA-based anti-CoV technologies.
- Analysis of antisense oligonucleotides (ASOs), siRNAs, CRISPR-Cas systems, and mRNA vaccines.
- Exploration of improved delivery systems and combination therapeutic strategies.
Main Results:
- Identified several promising NA-based technologies for targeting coronaviruses.
- Highlighted the potential of ASOs, siRNAs, CRISPR-Cas, and mRNA vaccines.
- Discussed the importance of optimized delivery and combination therapies.
Conclusions:
- Nucleic acid-based treatments represent a significant therapeutic avenue against coronaviruses.
- Further research into delivery systems and combination strategies is crucial for clinical translation.
- These technologies hold potential for future pandemic preparedness and response.
Related Concept Videos
Viruses with RNA Genomes
Nucleic acids
DNA and RNA
The two main types of nucleic acids are deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). DNA is the genetic material in all living organisms, ranging from single-celled bacteria to multicellular mammals. It is in the nucleus of eukaryotes and in the organelles, chloroplasts, and mitochondria. In prokaryotes,...
RNA-seq
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...

